This program is offered free of charge, but registration is required. Click here to register to attend.
Learn how CyTOF can spur advances in your oncology research.
Immunotherapy holds great potential for hematological and solid tumor cancers. The dawn of personalized treatment is on the horizon and the minds of scientists around the world, and as a research discipline, oncological immunotherapy’s challenges are many.
We invite you to this phenotyping webinar on strategies for personalizing cancer treatments and improving immunotherapy outcomes. Speakers will discuss their first-hand experiences phenotyping with mass cytometry and single-cell genomics technologies. You’ll learn the latest ways CyTOF® can supercharge your immunotherapy research and fuel your success.
Together we can make more progress in the battle against cancer. Take this opportunity to join the conversation and be part of the solution.
CARTography: A Mass Cytometry-Based Approach to Deep Phenotyping of Anti-CD19 CART Cells
Piotr Pierog, PhD, Senior Scientist, Novartis
Piotr Pierog will present on using mass cytometry to phenotype anti-CD19 CART cells and translating cell-product heterogeneity to patient outcomes.
Improving Cancer Immunotherapy Using Single-Cell Biomarkers and Phenotyping
Doug Hinerfield, PhD, Senior Application Scientist, FluidigmDoug Hinerfeld will guide your through the newest technologies for single-cell analysis at the genomic, proteomic and transcriptomic levels.